AZD6738
A Phase Ib Study of AZD6738 for Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Progressing on Front-Line Therapy
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 52 patients (estimated)
- Sponsors
- Massachusetts General Hospital
- Collaborators
- AstraZeneca
- Tags
- Kinase Inhibitor
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1560
- NCT Identifier
- NCT03770429
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.